Skip to main content
Premium Trial:

Request an Annual Quote

Women the World Over Rejoice

A new DNA test from Qiagen outperforms Pap smears in detecting the virus behind cervical cancer, reports the New York Times. An article in the New England Journal of Medicine looks into the effectiveness of human papillomavirus testing versus cytologic testing versus visual inspection of the cervix with acetic acid on of cervical cancer incidence and death in India. After eight years of follow-up, the authors report that a single round of HPV testing was associated with a decline in cervical cancer and death as compared to an uninspected control group, while the other groups showed no reduction as compared to the control. An NEJM editorial adds, "The implications of the findings of this trial are immediate and global: international experts in cervical-cancer prevention should now adapt HPV testing for widespread implementation." With funding from the Gates Foundation, Qiagen has developed a $5 version of the test.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.